Search PubMed⌕ Search

Biomedical subjects

David Zygun

Publications and source records attributed to David Zygun.

6 recordsLinked to original sources

Management following resuscitation from cardiac arrest: recommendations from the 2003 Rocky Mountain Critical Care Conference.

PURPOSE: To propose a strategy for the management of patients admitted to critical care units after resuscitation from cardiac arrest. SOURCE: Prior to the conference relevant studies were identified via literature searches and brief reviews circulated on the following topics: glucose and blood pressure management; therapeutic hypothermia; prearrest outcome prediction; post-arrest outcome prediction; and management of myocardial ischemia. Two days were devoted to assessing evidence and developing a management strategy at the conference. Consensus opinion of conference participants [intensive care unit (ICU) physicians] was used when high grade evidence was unavailable. Additional literature searches and data grading were performed post-conference. PRINCIPAL FINDINGS: High grade evidence was lacking in most areas. Specific goals of treatment were proposed for: general care; neurologic care; respiratory care; cardiac care; and gastrointestinal care. There was adequate evidence to recommend therapeutic hypothermia for comatose patients who had witnessed ventricular fibrillation or ventricular tachycardia arrests. Conference participants supported extending therapeutic hypothermia to other presenting rhythms in selected circumstances. Additional goals included mean arterial pressure 80 to 100 mmHg, glucose 5 to 8 mmol.L(-1) using insulin infusions, and PaO(2) > 100 mmHg for the first 24 hr. Absent withdrawal to pain 72 hr after resuscitation should prompt consideration of palliative care. The level of evidence for other recommendations was low. CONCLUSIONS: The proposed management strategy represents an approach to manage patients in the ICU following resuscitation from cardiac arrest. Most of the recommendations are based on low grade evidence. Additional research is needed to improve the evidence base. A standard post-arrest management strategy could help facilitate future research.

Blood Pressure↗

Non-neurological organ dysfunction in neurocritical care: impact on outcome and etiological considerations.

PURPOSE OF REVIEW: Organ dysfunction is an important determinant of outcome in critical care medicine. Patients with life threatening neurologic injury represent a distinct subset of critically ill patients in whom non-neurologic organ dysfunction may develop. In this paper the incidence and impact of non-neurologic organ dysfunction in patients with major neurologic injury will be reviewed. Further, potential etiological considerations will be addressed and management strategies discussed. RECENT FINDINGS: Non-neurologic organ dysfunction is extremely common in patients with brain injury occurring in 80-90% of patients admitted to intensive-care units. Several studies have now identified this dysfunction as an independent predictor of poor outcome in neurocritical care. This dysfunction may arise as a result of the neurologic injury or secondary to treatment. Massive catecholamine release continues to be the primary etiological theory of non-neurologic organ dysfunction due to brain injury. Currently employed therapies directed at intracranial hypertension such as maintenance of cerebral perfusion pressure and the use of hypothermia or barbiturates predispose non-neurologic organ dysfunction. SUMMARY: Non-neurologic organ dysfunction is common. This dysfunction independently predicts poor outcome following brain injury and represents a potentially modifiable risk factor. Further study is required to develop optimal management strategies.

Brain Injuries↗

Endovascular stent grafts for acute blunt aortic injury.

BACKGROUND: Endovascular stent grafting (EVSG) has emerged as a new treatment for aortic disease and has recently been applied to the treatment of acute blunt aortic injury (BAI). The purpose of this study was to determine the outcome of EVSG for patients with BAI at two tertiary (Level I) trauma centers. METHODS: A retrospective review of patients treated between January 1, 1999, and February 1, 2003, at two centers, Calgary Health Region (Calgary, Alberta) and Harborview Medical Center (Seattle, WA), with EVSG for acute BAI is reported. Variables assessed included age, sex, Injury Severity Score, total length of stay (LOS), intensive care unit LOS, operative technique, complications, technical success, mortality, and follow-up data. RESULTS: Twenty-eight patients treated with EVSG for BAI were identified during this period. Twelve patients were excluded because injuries occurred more than 30 days before grafting (n = 7) or under a different protocol (n = 4), or the procedure was performed in a different center (n = 1). Sixteen patients with acute BAI were reviewed. The mean Injury Severity Score was 36.9 (SD, 17.0), with a median intensive care unit LOS of 7.5 days (interquartile range, 1-17 days) and total LOS of 24.5 days (interquartile range, 7-41 days). Mean follow-up was 10.7 months (range, 3-30 months). Technical success was achieved in all patients, no graft-related complications have been detected during follow-up, and no patient developed postoperative paraplegia. One postoperative mortality occurred secondary to severe comorbid injury. A single patient with a preoperative traumatic carotid dissection demonstrated a postoperative stroke, and one patient required thoracentesis for a pleural effusion. CONCLUSION: Repair of BAI with EVSG can be performed safely in patients with BAI. Mortality, morbidity, and especially paraplegia are reduced. Further long-term studies are required to support the routine use of EVSG technology for BAI.

Acute Disease↗

Pulse pressure variation predicts fluid responsiveness following coronary artery bypass surgery.

STUDY OBJECTIVE: To determine whether the degree of pulse pressure variation (PPV) and systolic pressure variation (SPV) predict an increase in cardiac output (CO) in response to volume challenge in postoperative patients who have undergone coronary artery bypass grafting (CABG), and to determine whether PPV is superior to SPV in this setting. DESIGN AND SETTING: This was a prospective clinical study conducted in the cardiovascular ICU of a university hospital. PATIENTS: Twenty-one patients were studied immediately after arrival in the ICU following CABG. INTERVENTION: A fluid bolus was administered to all patients. MEASUREMENTS: Hemodynamic measurements, including central venous pressure (CVP), pulmonary artery occlusion pressure (PAOP), CO (thermodilution), percentage of SPV (%SPV), and percentage of PPV (%PPV), were performed shortly after patient arrival in the ICU. Patients were given a rapid 500-mL fluid challenge, after which hemodynamic measurements were repeated. Patients whose CO increased by >/= 12% were considered to be fluid responders. The ability of different parameters to distinguish between responders and nonresponders was compared. RESULTS: In response to the volume challenge, 6 patients were responders and 15 were nonresponders. Baseline CVP and PAOP were no different between these two groups. In contrast, the %SPV and the %PPV were significantly higher in responders than in nonresponders. Receiver operating characteristic curve analysis suggested that the %PPV was the best predictor of fluid responsiveness. The ideal %PPV threshold for distinguishing responders from nonresponders was found to be 11. A PPV value of >/= 11% predicted an increase in CO with 100% sensitivity and 93% specificity. CONCLUSION: PPV and SPV can be used to predict whether or not volume expansion will increase CO in postoperative CABG patients. PPV was superior to SPV at predicting fluid responsiveness. Both of these measures were far superior to CVP and PAOP.

Blood Pressure↗